Medistep Healthcare Limited (NSE:MEDISTEP)
India · Delayed Price · Currency is INR 19.75
+0.80 (4.22%)
At close: Aug 24, 2026
Medistep Healthcare Revenue
In the fiscal year ending March 31, 2026, Medistep Healthcare had annual revenue of 708.31M INR with 42.65% growth.
Revenue
708.31M
Revenue Growth
+42.65%
P/S Ratio
0.40
Revenue / Employee
n/a
Employees
n/a
Market Cap
280.64M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 708.31M | 211.76M | 42.65% |
| Mar 31, 2025 | 496.55M | 105.83M | 27.09% |
| Mar 31, 2024 | 390.72M | 114.25M | 41.33% |
| Mar 31, 2023 | 276.47M | 200.22M | 262.61% |
| Mar 31, 2022 | 76.24M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Centuple Global | 5.62B |
| Dipna Pharmachem | 1.29B |
| Chandra Bhagat Pharma | 1.17B |
| VijayPD Ceutical | 1.04B |
| Medico Intercontinental | 845.82M |
| Zenlabs Ethica | 496.22M |
| Constronics Infra | 454.43M |
| Goldline Pharmaceutical | 311.98M |